4-1BB/Nectin-4 bispecific antibody program (Twist Bioscience)

N/A

Report date: 2025/06/11 10:53:01

Base Information

Drug Name4-1BB/Nectin-4 bispecific antibody program (Twist Bioscience)
Drug Alias NameCD137/Nectin-4 bispecific antibody program (Twist Bioscience)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsImmunostimulantsNectin-4 modulators +[4] 
TargetsNectin-4Tumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTwist Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesTwist Bioscience Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A